Zdrowie i gospodarka · 18.08.1999
Draft Guidance for Industry on Levothyroxine Sodium; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Levothyroxine Sodium.'' The draft guidance is intended to answer questions concerning applications for orally administered levothyroxine sodium drug products.